Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.

Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.

Pediatr Nephrol. 2013 May;28(5):737-43. doi: 10.1007/s00467-012-2372-9. Epub 2012 Dec 4.

PMID:
23207876
2.

Comparison of the intrinsic vasorelaxant and inotropic effects of the antiarrhythmic agents vernakalant and flecainide in human isolated vascular and cardiac tissues.

Lynch JJ Jr, Regan CP, Beatch GN, Gleim GW, Morabito CJ.

J Cardiovasc Pharmacol. 2013 Mar;61(3):226-32. doi: 10.1097/FJC.0b013e31827afd29.

PMID:
23188129
3.

Losartan and enalapril are comparable in reducing proteinuria in children.

Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.

Kidney Int. 2012 Oct;82(7):819-26. doi: 10.1038/ki.2012.210. Epub 2012 Jun 27.

4.

Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.

Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C.

Nephrol Dial Transplant. 2011 Aug;26(8):2521-6. doi: 10.1093/ndt/gfq797. Epub 2011 Feb 1.

PMID:
21285125
5.

Randomized, double-blind, controlled study of losartan in children with proteinuria.

Webb NJ, Lam C, Loeys T, Shahinfar S, Strehlau J, Wells TG, Santoro E, Manas D, Gleim GW.

Clin J Am Soc Nephrol. 2010 Mar;5(3):417-24. doi: 10.2215/CJN.06620909. Epub 2010 Jan 14.

6.

The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.

Fossum E, Gleim GW, Kjeldsen SE, Kizer JR, Julius S, Devereux RB, Brady WE, Hille DA, Lyle PA, Dahlöf B.

J Intern Med. 2007 Oct;262(4):439-48.

7.

Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D.

J Am Soc Nephrol. 2007 May;18(5):1540-6. Epub 2007 Apr 4.

9.

The impact of morbid events on survival following hospitalization for complicated myocardial infarction.

Dickstein K, Gleim GW, Snapinn S, James MK, Kjekshus J; OPTIMAAL Study Group.

Eur J Heart Fail. 2006 Jan;8(1):74-80. Epub 2005 Aug 2.

10.

Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

Zhang Z, Shahinfar S, Keane WF, Ramjit D, Dickson TZ, Gleim GW, Mogensen CE, de Zeeuw D, Brenner BM, Snapinn SM.

J Am Soc Nephrol. 2005 Jun;16(6):1775-80. Epub 2005 May 4.

11.

Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.

Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S.

Am J Cardiovasc Drugs. 2005;5(1):17-22. Review.

PMID:
15631534
12.

The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.

Fox JC, Leight K, Sutradhar SC, Demopoulos LA, Gleim GW, Lewin AJ, Bakris GL.

J Clin Hypertens (Greenwich). 2004 Aug;6(8):437-42; quiz 443-4.

13.

Effects of losartan on diabetic maculopathy in type 2 diabetic patients.

Gleim GW, Tressler CS.

J Intern Med. 2004 Feb;255(2):304-5; author reply 306-7. No abstract available.

14.

Changes in serum sodium, sodium balance, water balance, and plasma hormone levels as the result of pelvic surgery in women.

Amede FJ, James KA, Michelis MF, Gleim GW.

Int Urol Nephrol. 2002;34(4):545-50.

PMID:
14577502
15.

Electromyographic predictors of residual quadriceps muscle weakness after anterior cruciate ligament reconstruction.

McHugh MP, Tyler TF, Browne MG, Gleim GW, Nicholas SJ.

Am J Sports Med. 2002 May-Jun;30(3):334-9.

PMID:
12016072
16.

Differences in activation patterns between eccentric and concentric quadriceps contractions.

McHugh MP, Tyler TF, Greenberg SC, Gleim GW.

J Sports Sci. 2002 Feb;20(2):83-91.

PMID:
11811575
17.
18.

Electromyographic analysis of repeated bouts of eccentric exercise.

McHugh MP, Connolly DA, Eston RG, Gartman EJ, Gleim GW.

J Sports Sci. 2001 Mar;19(3):163-70.

PMID:
11256821
19.

Electromyographic analysis of quadriceps fatigue after anterior cruciate ligament reconstruction.

McHugh MP, Tyler TF, Nicholas SJ, Browne MG, Gleim GW.

J Orthop Sports Phys Ther. 2001 Jan;31(1):25-32.

PMID:
11204793
20.

Quantification of posterior capsule tightness and motion loss in patients with shoulder impingement.

Tyler TF, Nicholas SJ, Roy T, Gleim GW.

Am J Sports Med. 2000 Sep-Oct;28(5):668-73.

PMID:
11032222
21.

6MP for fathers with IBD at the time of conception: the value of a large clinical experience over unrelated controls.

Korelitz BI, Rajapakse RO, Zlatanic J, Baiocco PJ, Gleim GW.

Am J Gastroenterol. 2000 Sep;95(9):2386-7. No abstract available.

PMID:
11007251
22.

Electromyographic analysis of exercise resulting in symptoms of muscle damage.

McHugh MP, Connolly DA, Eston RG, Gleim GW.

J Sports Sci. 2000 Mar;18(3):163-72.

PMID:
10737267
23.

Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.

Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW.

Am J Gastroenterol. 2000 Mar;95(3):684-8.

PMID:
10710057
24.

Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.

Kim PS, Zlatanic J, Korelitz BI, Gleim GW.

Am J Gastroenterol. 1999 Nov;94(11):3254-7.

PMID:
10566725
25.

Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.

Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.

Am J Gastroenterol. 1999 Nov;94(11):3248-53.

PMID:
10566724
26.

Association of KT-1000 measurements with clinical tests of knee stability 1 year following anterior cruciate ligament reconstruction.

Tyler TF, McHugh MP, Gleim GW, Nicholas SJ.

J Orthop Sports Phys Ther. 1999 Sep;29(9):540-5.

PMID:
10518296
27.

The role of passive muscle stiffness in symptoms of exercise-induced muscle damage.

McHugh MP, Connolly DA, Eston RG, Kremenic IJ, Nicholas SJ, Gleim GW.

Am J Sports Med. 1999 Sep-Oct;27(5):594-9.

PMID:
10496575
28.

Large sessile colonic adenomas: use of argon plasma coagulator to supplement piecemeal snare polypectomy.

Zlatanic J, Waye JD, Kim PS, Baiocco PJ, Gleim GW.

Gastrointest Endosc. 1999 Jun;49(6):731-5.

PMID:
10343218
29.

Reliability and validity of a new method of measuring posterior shoulder tightness.

Tyler TF, Roy T, Nicholas SJ, Gleim GW.

J Orthop Sports Phys Ther. 1999 May;29(5):262-9; discussion 270-4.

PMID:
10342563
30.

Exercise-induced muscle damage and potential mechanisms for the repeated bout effect.

McHugh MP, Connolly DA, Eston RG, Gleim GW.

Sports Med. 1999 Mar;27(3):157-70. Review.

PMID:
10222539
31.

The effect of immediate weightbearing after anterior cruciate ligament reconstruction.

Tyler TF, McHugh MP, Gleim GW, Nicholas SJ.

Clin Orthop Relat Res. 1998 Dec;(357):141-8.

PMID:
9917711
32.

Percentage body fat determination in hemodialysis and peritoneal dialysis patients: a comparison.

Stall S, Ginsberg NS, DeVita MV, Zabetakis PM, Lynn RI, Gleim GW, Wang J, Pierson RN, Michelis MF.

J Ren Nutr. 1998 Jul;8(3):132-6.

PMID:
9724502
33.

Relation between single tomographic intravascular ultrasound image parameters and intracoronary Doppler flow velocity in patients with intermediately severe coronary stenoses.

Moses JW, Undermir C, Strain JE, Kreps EM, Higgins JE, Gleim GW, Kern MJ.

Am Heart J. 1998 Jun;135(6 Pt 1):988-94.

PMID:
9630102
34.

CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.

Pecora AL, Preti RA, Gleim GW, Jennis A, Zahos K, Cantwell S, Doria L, Isaacs R, Gillio AP, Michelis MA, Brochstein JA.

J Clin Oncol. 1998 Jun;16(6):2093-104.

PMID:
9626209
35.

The role of mechanical and neural restraints to joint range of motion during passive stretch.

McHugh MP, Kremenic IJ, Fox MB, Gleim GW.

Med Sci Sports Exerc. 1998 Jun;30(6):928-32.

PMID:
9624653
36.

Preoperative indicators of motion loss and weakness following anterior cruciate ligament reconstruction.

McHugh MP, Tyler TF, Gleim GW, Nicholas SJ.

J Orthop Sports Phys Ther. 1998 Jun;27(6):407-11.

PMID:
9617726
37.

Effects of a 2-hour run on metabolic economy and lower extremity strength in men and women.

Glace BW, McHugh MP, Gleim GW.

J Orthop Sports Phys Ther. 1998 Mar;27(3):189-96.

PMID:
9513864
38.

Flexibility and its effects on sports injury and performance.

Gleim GW, McHugh MP.

Sports Med. 1997 Nov;24(5):289-99. Review.

PMID:
9368275
39.

Significance of WBC differential when leukopenia is induced by 6-MP for IBD.

Korelitz BI, Zlatanic J, Smith MJ, Lipe RJ, Baiocco PJ, Gleim GW.

Gastroenterology. 1997 Nov;113(5):1810-1. No abstract available.

PMID:
9352894
40.

Comparison of five body-composition methods in peritoneal dialysis patients.

Stall SH, Ginsberg NS, DeVita MV, Zabetakis PM, Lynn RI, Gleim GW, Wang J, Pierson RN Jr, Michelis MF.

Am J Clin Nutr. 1996 Aug;64(2):125-30.

PMID:
8694010
41.

Regulation of glucose turnover and hormonal responses during electrical cycling in tetraplegic humans.

Kjaer M, Pollack SF, Mohr T, Weiss H, Gleim GW, Bach FW, Nicolaisen T, Galbo H, Ragnarsson KT.

Am J Physiol. 1996 Jul;271(1 Pt 2):R191-9.

PMID:
8760220
42.

Exercise and heart rate variability.

Lazoglu AH, Glace B, Gleim GW, Coplan NL.

Am Heart J. 1996 Apr;131(4):825-6. No abstract available.

PMID:
8721662
43.

Fluid balance and renal response following dehydrating exercise in well-trained men and women.

Stachenfeld NS, Gleim GW, Zabetakis PM, Nicholas JA.

Eur J Appl Physiol Occup Physiol. 1996;72(5-6):468-77.

PMID:
8925818
44.

Viscoelastic response to repeated static stretching in the human hamstring muscle.

Magnusson SP, Simonsen EB, Aagaard P, Gleim GW, McHugh MP, Kjaer M.

Scand J Med Sci Sports. 1995 Dec;5(6):342-7.

PMID:
8775718
45.

Effects of blood donation on exercise performance in competitive cyclists.

Panebianco RA, Stachenfeld N, Coplan NL, Gleim GW.

Am Heart J. 1995 Oct;130(4):838-40.

PMID:
7572594
46.

Strength profiles and performance in Masters' level swimmers.

Magnusson SP, Constantini NW, McHugh MP, Gleim GW.

Am J Sports Med. 1995 Sep-Oct;23(5):626-31.

PMID:
8526281
47.

Death from Crohn's disease. Lessons from a personal experience.

Mendelsohn RR, Korelitz BI, Gleim GW.

J Clin Gastroenterol. 1995 Jan;20(1):22-6.

PMID:
7884172
48.

Comparison of submaximal treadmill and supine bicycle exercise.

Coplan NL, Sacknoff DM, Stachenfeld NS, Gleim GW.

Am Heart J. 1994 Aug;128(2):416-8. No abstract available.

PMID:
8037113
49.

Effect of anterior cruciate ligament deficiency on economy of walking and jogging.

McHugh MP, Spitz AL, Lorei MP, Nicholas SJ, Hershman EB, Gleim GW.

J Orthop Res. 1994 Jul;12(4):592-7.

PMID:
8064488
50.

Systemic effects of ingesting varying amounts of a commercial carbohydrate beverage postexercise.

Glace BW, Gleim GW, Zabetakis PM, Nicholas JA.

J Am Coll Nutr. 1994 Jun;13(3):268-76.

PMID:
8077576

Supplemental Content

Loading ...
Support Center